Research Results - (PDF, 101 mb) - USAID
Research Results - (PDF, 101 mb) - USAID
Research Results - (PDF, 101 mb) - USAID
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
nymphs and adults. However, a high nu<strong>mb</strong>er<br />
of DNA extracts of nymphs fed as larvae and<br />
adults fed as nymphs on heartwater-infected<br />
goats bound to the DNA probes. Based on the<br />
relative specificity, we are currently pursuing<br />
the use of pCS20 in epidemiological and other<br />
studies. In addition, the DNA sequence is being<br />
determined so that the probe can be widely<br />
used. For instance, investigators in other countries<br />
can make synthetic oligonucleotide probes<br />
from the DNA sequence and not have to obtain<br />
the DNA probe.<br />
Project Achievements<br />
1. Development of a DNA probe for C.<br />
ruminantiumand detection of individual infected<br />
ticks.<br />
2. Completion of Dr. Suryakant Waghela's<br />
Ph.D. program.<br />
Changes in Workplan<br />
The focus on identification of surface<br />
proteins was temporarily interrupted in order to<br />
characterize the DNA probes to detect organisms.<br />
The primary reason was to complete Dr.<br />
Waghela's Ph.D. program.<br />
Activity No. 3. Contagious Caprne<br />
Pleuropneumonia (CCPP) Vaccine.<br />
Objective<br />
Immunize goats with expressed F38<br />
surfce einie tats with etra 3proteins g<br />
surface protein that reacts with neutralizing<br />
monoclonal antibody.<br />
Problem Statement and Approach<br />
CCPP is the most serious disease of goats<br />
in Kenya, causing high mortality and great<br />
economic loss. The disease occurs in epidemics<br />
in all areas of the country, including western<br />
Kenya. The SR-CRSP project and KARI developed<br />
an inactivated vaccine for CCPP. This<br />
vaccine is very effective and one dose induces<br />
protection for at least one year. All the SR-CRSP<br />
90<br />
goats and the KARI goats are routinely vaccinated.<br />
In addition, several hundred thousand<br />
doses of vaccine have been distributed to farmers<br />
in Kenya. There is a high demand for the<br />
vaccine by farmers and several million doses are<br />
needed. We continue to work with government<br />
and commercial sources to get more vaccine<br />
made.<br />
Since we have considerable experience<br />
with the CCPP system, it is a logical target for<br />
initial inclusion in a multivalent reco<strong>mb</strong>inant<br />
vaccine for goats. To this end, we are identifying<br />
F38 proteins expressed by reco<strong>mb</strong>inant organisms.<br />
Justification<br />
Delivery of individual monovalent<br />
vaccines, several of which are required to<br />
protect against the important goat diseases, is<br />
not possible in the case of farmers with a small<br />
nu<strong>mb</strong>er of goats and limited resources. Therefore,<br />
multivalent vaccines are needed and to<br />
incorporate CCPP antigens into a multivalent<br />
format, we are using reco<strong>mb</strong>inant DNA to<br />
obtain F38 surface proteins.<br />
Project Progress<br />
The plan was to use a monoclonal antibody<br />
developed by SR-CRSP that causes<br />
growth-inhibition of F38 to identify an F38<br />
surface protein expressed in a genomic DNA<br />
library. Initial experiments were done to verify<br />
that the monoclonal antibody bound to a protein<br />
epitope, providing a rationale for screening<br />
expressed by reco<strong>mb</strong>inant E.coli that<br />
are not glycosylated. The carbohydrate antigen<br />
that is used in the latex agglutination test was<br />
found to block the growth-inhibition caused by<br />
the monoclonal antibody. This indicated that<br />
the monoclonal antibody recognized a carbohydrate<br />
epitope and could not be used to screen<br />
the E.coli reco<strong>mb</strong>inants expressing F38 proteins.<br />
An antibody was needed that reacted<br />
with F38 surface proteins and could be used for<br />
immunoscreening. To obtain this antibody,<br />
large nu<strong>mb</strong>ers of F38 organisms were grown,<br />
isolated, and reacted with complement inacti